…although the risk of getting pancreatitis is pretty small in any case.
DPP-4 inhibitors are sometimes called gliptins. They’re used to treat type 2 diabetes.
From Diabetes Care:
“CONCLUSIONS Treatment with gliptins significantly increased the risk for acute pancreatitis in a combined analysis of three large controlled randomized trials.”
Source: Diabetes Care
Speaking of risk reduction, lower your risk of being prescribed a gliptin by reducing your carbohydrate consumption.